Index
BrightHeart is a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, with an AI software platform that delivers support across the entire ultrasound exam, providing guidance at every step for expert-level screening, automated view recognition, precise tracking of the full anatomy, and efficient evaluations. Its FDA-cleared and CE-marked medical devices integrate directly into routine ultrasound workflows to deliver best-in-class critical organ evaluation, improve exam completeness, save time, and support confident clinical decision-making without disrupting how clinicians work.
We are rapidly expanding our team on the heels of our €11M Series A closed earlier this year, with a focus on scaling commercially in the US and Europe and broadening our offering.
We are funded and incubated by Sofinnova MD Start III, an efficient 3-in-1 "accelerator" structure. Their mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and their continued funding. Their team operates the projects and builds new companies to bridge the gap between science and clinical experience. Through this, BrightHeart benefits from a robust network of strategics, advisors, and investors.
We are currently a small team with experience in the field, working with expert partners, and funded. We want to move fast by hiring top level talents!
More info: https://www.brightheart.ai
At BrightHeart, we believe every single fetal ultrasound screening exam should be performed with the highest level of accuracy, so each mother and baby receive the highest possible quality of care.